Drug Markets/Granisetron

Granisetron

1 NDC across 1 manufacturer|0 Generic,1 Brand

▸ More about this market

The brand product was first FDA-approved on Sep 12, 2008. In 2024, Medicare Part D spent $7 million on Granisetron across 3,294 claims for 1,258 beneficiaries.

Granisetron is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $685.85 to $685.85 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$685.85 – $685.85

per EA

7d Activity

1↓0 flat

avg -0.1% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing GRANISETRON

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
SANCUSO 3.1 MG/24 HR PATCH
$685.8523
per EA
-0.09%

Frequently Asked Questions

How much does Medicare spend on Granisetron?

In 2024, Medicare Part D spent $7 million on Granisetron across 3,294 claims for 1,258 beneficiaries.

How many Granisetron products are on the market?

The Granisetron drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Granisetron?

NADAC reference prices for Granisetron range from $685.8523 to $685.8523 per EA.

Which manufacturers make Granisetron?

1 manufacturer lists Granisetron in NADAC. Ranked by number of NDCs, the largest are Cumberland Pharmaceuticals Inc. (1).

How has the price of Granisetron changed recently?

Over the past 7 days, 0 Granisetron NDCs rose and 1 fell, with a market-wide average change of -0.1%.